A Randomized Single Dose Crossover Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of CTP-692 Versus D-Serine
Phase of Trial: Phase I
Latest Information Update: 31 Dec 2018
At a glance
- Drugs Deuterated D-Serine (Primary) ; D-serine
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Concert Pharmaceuticals
- 17 Dec 2019 According to a Concert Pharmaceuticals media release, initial data from this trial is expected in the first quarter of 2019.
- 17 Dec 2018 Status changed from planning to recruiting.
- 02 Aug 2018 According to a Concert Pharmaceuticals media release, the company expects to initiate this trial the fourth quarter 2018.